Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03023124
Title Study With Trabectedin Versus Adriamycin Plus Dacarbazine, in Patients With Advanced Solitary Fibrous Tumor (STRADA)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Italian Sarcoma Group
Indications

solitary fibrous tumor/hemangiopericytoma

Therapies

Trabectedin

Dacarbazine + Doxorubicin

Age Groups: senior | adult
Covered Countries


No variant requirements are available.